BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11681869)

  • 1. Canine idiopathic dilated cardiomyopathy. Part II: pathophysiology and therapy.
    Borgarelli M; Tarducci A; Tidholm A; Häggström J
    Vet J; 2001 Nov; 162(3):182-95. PubMed ID: 11681869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the pathophysiology is the key to novel therapies for canine dilated cardiomyopathy.
    Elliott J; Marr CM
    Vet J; 2001 Nov; 162(3):168-9. PubMed ID: 11681866
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathophysiology and current therapy of congestive heart failure due to idiopathic cardiomyopathy].
    Kambayashi M; Kumada T
    Nihon Rinsho; 1993 May; 51(5):1328-32. PubMed ID: 8101239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].
    Bai R; Pu J; Liu N; Lu JG; Zhou Q; Ruan YF; Niu HY; Wang L
    Sheng Li Xue Bao; 2003 Dec; 55(6):722-30. PubMed ID: 14695492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte beta -adrenoceptor downregulation in great danes with occult dilated cardiomyopathy (DCM) and with DCM and heart failure.
    Borgarelli M; Badino P; Bergamasco L; Bussadori C; Odore R; Re G; Tarducci A; Dotta U
    Vet J; 1999 Sep; 158(2):128-34. PubMed ID: 10489269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic alternatives in dilated cardiomyopathy--a review of current options.
    Kleber FX
    Eur Heart J; 1991 Aug; 12 Suppl D():197-9. PubMed ID: 1680688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine idiopathic dilated cardiomyopathy. Part I: Aetiology, clinical characteristics, epidemiology and pathology.
    Tidholm A; Häggström J; Borgarelli M; Tarducci A
    Vet J; 2001 Sep; 162(2):92-107. PubMed ID: 11531394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic characterization of canine dilated cardiomyopathy.
    Tidholm A; Jönsson L
    Vet Pathol; 2005 Jan; 42(1):1-8. PubMed ID: 15657266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases.
    Martin MW; Stafford Johnson MJ; Strehlau G; King JN
    J Small Anim Pract; 2010 Aug; 51(8):428-36. PubMed ID: 20670255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of digoxin administration in dogs with idiopathic congestive cardiomyopathy.
    Kittleson MD; Eyster GE; Knowlen GG; Olivier NB; Anderson LK
    J Am Vet Med Assoc; 1985 Jan; 186(2):162-5. PubMed ID: 3972674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of medical therapy on survival of patients with dilated cardiomyopathy.
    Calvert CA
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):919-30. PubMed ID: 1683046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up to date in pharmacological treatment of dilated cardiomyopathy.
    Ginghina C; Teodorescu A; Stoian I; Serban M; Ghiorghiu I; Wohlfart K
    Rom J Intern Med; 2004; 42(1):3-13. PubMed ID: 15529591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].
    Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G
    Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15185463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of dilated cardiomyopathies. Recent findings].
    Perret C
    Ann Cardiol Angeiol (Paris); 1986 Jun; 35(6):311-6. PubMed ID: 2877610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
    Jahns R; Boivin V; Lohse MJ
    Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.